News

Technology News

ForteBio Launches Drug Development Biosensor

Thursday, January 10, 2013 5:03:00 AM PDT | VentureDeal
   Port Washington, New York  --  Biotechnology analysis company ForteBio has announced the launch of a new bio therapeutic drug development biosensor.

Called the Dip and Read Anti-Human Fab-CH1 Biosensor, Zinsser promises to provide an "easy and rapid method for quantitation and kinetic characterization of human Fab, F9ab')2 and IgC", which are critical to drug discovery efforts.

The biosensors are designed for use in the company's Octet and BLItz analysis instrumentation systems.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1